The $61B Lesson: Every Defense Tech Giant Started With a Government Grant
The best-performing venture asset class of the decade wasn't funded by venture capital first. It was funded by the Pentagon.
Anduril is worth $61 billion. Shield AI just hit $12.7 billion. Saronic went from founding to $9.25 billion in under four years.
Here's what most people miss about these companies: none of them started with a mega-round. They started with government money.
Before the billion-dollar raises, there were SBIR awards, DIU prototype contracts, and AFWERX programs. Small checks by venture standards — but checks that validated the technology, opened doors to program offices, and gave investors the confidence to follow.
If you're building defense or dual-use technology, this is the most important pattern in the industry right now. Let's walk through it.
The Receipts
Palantir is the original template. Before it became a ~$310 billion public company, its earliest institutional backing came from In-Q-Tel — the CIA's venture arm. Government adoption came first. Commercial scale and public-market validation followed.
Anduril was founded in 2017, when defense was still an unfashionable category for VCs. Its first contract — $12.5 million from the U.S. Marine Corps — came about a year in. By 2020, it beat legacy primes head-to-head for a $1 billion program. Today: $2B+ in annual revenue, an Army enterprise agreement with a ceiling up to $20 billion, and a $5 billion Series H closed in May 2026 at a $61 billion valuation.
Shield AI landed its first major contract in 2016 through the Defense Innovation Unit's autonomy program. In 2022, it won a $60 million AFWERX STRATFI award — the "bridge" funding designed to carry technologies across the valley of death. That bridge worked: its Hivemind software was selected for the Air Force's Collaborative Combat Aircraft program in early 2026, and weeks later the company raised at $12.7 billion — more than double its valuation a year earlier.
Epirus ran the sequence deliberately: SBIR awards and OTA agreements first, then a $66 million Army contract for its Leonidas counter-drone system in 2023. It has since raised over $550 million at a unicorn valuation.
Saronic was founded in 2022. A $392 million Navy contract anchored its credibility. By March 2026: $1.75 billion raised at $9.25 billion.
The Pattern
Four things happened at every one of these companies:
1. Early non-dilutive awards validated the technology before large private checks arrived.
2. Government programs opened doors. SBIR and DIU contracts are a "license to hunt" — direct access to program offices and the end users who actually buy things.
3. Each award de-risked the next round. Investors consistently cite contract traction, not just technology, as the trigger for major rounds. Shield AI's valuation more than doubled within weeks of its CCA selection. In today's defense ecosystem, government contract traction is the investment thesis.
4. Enterprise value was created in the transition — from prototype dollars (SBIR Phase I/II) to programs of record (Phase III, STRATFI, production contracts).
Here's the hard part
Billions of dollars flow through SBIR/STTR, AFWERX, STRATFI, TACFI, DIU, DARPA, ONR, and APFIT every year. But this funding remains intensely competitive — and great technology alone doesn't win it.
Evaluators expect technical maturity, mission relevance, transition pathways, commercialization strategy, budget discipline, and federal acquisition compliance. Most innovative companies struggle not because their technology falls short, but because they've never navigated the government funding ecosystem.
The challenge isn't a shortage of innovation. It's translating innovation into proposals agencies are prepared to fund.
The companies above solved that translation problem early. Most companies never do.
What the winners did differently
They treated non-dilutive funding as strategy, not lottery tickets:
- They identified the programs that matched their technology roadmap — not just the ones with open solicitations.
- They sequenced awards deliberately, building from feasibility to prototype to production.
- They built the compliance and transition infrastructure agencies require before they needed it.
- They integrated grants, contracts, and private capital into one coherent growth plan.
That's a discipline. And it's learnable — or hireable.
Where GMA comes in
For more than two decades, Grant Management Associates has helped organizations run this exact playbook — $2.5 billion+ in competitive funding secured across 500+ clients.
Our Defense & Tech practice combines perspectives you won't find in a typical grant shop: a retired Major General who managed defense portfolios up to $17 billion inside the Office of the Secretary of Defense; a national DoD grant strategist who architected $230 million+ in defense initiatives; and Sonia Vohnout, one of the country's foremost SBIR/STTR and commercialization experts with 30+ years of experience across DoD, DARPA, NASA, and NIH.
We work the full lifecycle: program identification, readiness assessment, proposal development, compliance, and — critically — the transition planning that turns a Phase II award into a program of record.
The bottom line
The next Anduril, Shield AI, or Saronic is being founded right now. Its trajectory will be determined as much by its funding strategy as by its engineering.
If you're building technology with defense or dual-use potential, the question isn't whether non-dilutive capital exists for you. It's whether you have the strategy to win it.
Let's find out. Message me here on LinkedIn or reach GMA's Defense & Tech practice to schedule a complimentary funding strategy consultation — one conversation covering which federal programs fit your roadmap, where you stand against evaluator expectations, and what a realistic 12–24 month funding pathway looks like.
Don't leave equity on the table.
Grant Management Associates | $2.5B+ in competitive funding secured | 500+ clients served